HomeAI · summaries
Storia in 14 fonti
Dow Jones Top Company Headlines at 1 PM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | J.M. ...
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.
- ·
thehindubusinessline.com
GSK in talks to buy cancer biotech Nuvalent for more than $9 billion
GSK is in negotiations to acquire cancer biotech Nuvalent for over $9 billion amid a surge in biotech mergers.
